Epidemiology and risk factors of inflammatory bowel diseases;Épidémiologie et facteurs de risque des maladies inflammatoires chroniques de l'intestin

Revue du Praticien

Volumn 55, Issue 9, 2005, Pages 949-956

  Vernier, Gwenola ^b   Cortot, Antoine ^b   Gower Rousseau, Corinne ^b   Salomez, Jean Louis ^b   Colombel, Jean Frédéric ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

APPENDECTOMY; ASIA; CHROMOSOME 16; CIGARETTE SMOKING; DEVELOPING COUNTRY; EASTERN EUROPE; ENTERITIS; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENE LOCATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE SYSTEM; REVIEW; RISK FACTOR; TWINS; WESTERN HEMISPHERE; AGE DISTRIBUTION; GENETIC PREDISPOSITION; INCIDENCE; SEX RATIO;

AGE DISTRIBUTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; RISK FACTORS; SEX DISTRIBUTION;

EID: 20344407027     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Loftus EV. Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
2. Podolsky DK. Inflammatory Bowel Disease. N Engl J Med 2002;347:417-429.
3. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-73.
4. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
5. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
6. Shivananda S, Lennard-Jones J, Logan R et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-7.
7. Gower-Rousseau C, Salomez JL, Dupas JL et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-8.
8. Molinie F, Gower-Rousseau C, Yzet T et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004;53:813-8.
9. Flamenbaum M, Zenut M, Aublet-Cuvelier B et al. Incidence des maladies inflammatoires du tube digestif dans le département du Puyde-Dome en 1993 et 1994. EPIMICI. Epidemiologie des maladies inflammatoires cryptogénétiques de l'intestin group. Gastroenterol Clin Biol 1997;21:491-6.
10. Pagenault M, Tron I, Alexandre JL et al. Incidence des maladies inflammatoires du tube digestif en 8retagne (1994-1995). ABERMAD. Association bretonne d'étude et de recherche des maladies de l'appareil digesif. Gastroenterol Clin Biol 1997;21:483-90.
11. Armitage EL, Aldhous MC, Andersen N et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004;127:1051-7.
12. Ekbom A. The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm Bowel Dis 2004;10:S32-4.
13. Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:543-6.
14. Mayberry MK, Probert C, Srivastava E, Rhodes J, Mayberry JF. Perceived discrimination in education and employment by people with Crohn's disease: a case control study of educational achievement and employment. Gut 1992;33:312-4.
15. Fireman Z, Grossman A, Lilos P, Eshchar Y, Theodor E, Gilat T. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. Am J Gastroenterol 1989;84:255-8.
16. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-54.
17. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004;18:481-96.
18. Sandborn WJ, Tremaine WJ, Offord KP et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126:364-71.
19. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002;8:277-86.
20. Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998;43:494-8.
21. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001;344:808-14.
22. Cosnes J, Carbonnel F, Beaugerie L, Blaïn A, Reijasse D, Gendre JP. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002;51:803-7.
23. Koutroubakis IE, Vlachonikolis IG, Kapsoritakis A et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: case-controlled study in Crete. Dis Colon Rectum 1999;42:225-30.
24. Russel MG, Dorant E, Brummer RJ et al. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997;113:377-82.
25. Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol 2004;18:497-508.
26. Jarnerot G, Jarnmark I, Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983;18:999-1002.
27. Lomer MC, Thompson RP, Powell JJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc 2002;61:123-30.
28. Lerebours E, Gower-Rousseau C, Merle V et al. Are stressful life events a risk factor for inflammatory bowel disease onset? Results of a case-control study. (soumis).
29. Levenstein S, Prantera C, Varvo V et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994;89:1219-25.
30. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
31. Baron S, Turck D, Leplat C et al. Environmental risk factors in pediatric inflammatory bowel diseases: a population based case-control study. Gut 2005;54:357-63.
32. Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994;344:508-10.
33. Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996;348:515-7.
34. Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004;126:1533-49.
35. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Iterative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.
36. Lesage S, Zouali H, Cezard JP et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
37. Russell RK, Satsangi J. IBD: A family affair. Best Pract Res Clin Gastroenterol 2004;18:525-39.
38. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001;120:1093-9.